This study will assess the safety and effectiveness of GORE? CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.
Diagnosed with an ischemic stroke presumed to be an embolic stroke of undetermined source (ESUS) verified by a neurologist within the last 365 days prior to enrollment. Presence of Patent Foramen Ovale (PFO), as determined initially by positive bubble study utilizing transesophageal echocardiography (TEE) and/or transcranial Doppler (TCD), demonstrating spontaneous right-to-left shunting or right-to-left shunting during Valsalva maneuver. Patient is able to tolerate antiplatelet therapy
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Medical Center of the Rockies
Protocol Number: 19-6030
More information available at ClinicalTrials.gov: NCT03821129
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers